Patents by Inventor Galia Luboshits

Galia Luboshits has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of proliferative disorders with a chemiluminescent agent
    Patent number: 10092565
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminescent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: October 9, 2018
    Assignees: Semorex Technologies Ltd., Ariel-University Research and Development Company Ltd.
    Inventors: Bernard S. Green, Galia Luboshits, Michael A. Firer
  • TREATMENT OF PROLIFERATIVE DISORDERS WITH A CHEMILUMINESCENT AGENT
    Publication number: 20170014410
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminescent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Application
    Filed: September 29, 2016
    Publication date: January 19, 2017
    Applicants: Semorex Technologies Ltd., Ariel-University Research and Development Company Ltd.
    Inventors: Bernard S. GREEN, Galia LUBOSHITS, Michael A. FIRER
  • Treatment of proliferative disorders with a chemiluminescent agent
    Patent number: 9464079
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminiscent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: October 11, 2016
    Assignees: Semorex Technologies Ltd., Ariel-University Research and Development Company Ltd.
    Inventors: Bernard S. Green, Galia Luboshits, Michael A. Firer
  • TREATMENT OF PROLIFERATIVE DISORDERS WITH A CHEMILUMINESCENT AGENT
    Publication number: 20140010867
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminiscent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Application
    Filed: March 22, 2012
    Publication date: January 9, 2014
    Applicants: Ariel-University Research and Development Company Ltd., Semorex Technologies Ltd.
    Inventors: Bernard S. Green, Galia Luboshits, Michael A. Firer